Scholz: US tariffs attack on trade order - Breaking The News
Download our appPlay StoreApp Store

Scholz: US tariffs attack on trade order

EPA-EFE/TOLGA AKMEN / POOL

Outgoing German Chancellor Olaf Scholz echoed on Thursday the sentiment of other European leaders, denouncing United States tariffs and calling them "fundamentally wrong."

"This is an attack on a trade order that has created prosperity all over the globe, a trade order that is essentially the result of American efforts," Scholz mentioned during a press conference.

He underlined that Europe will respond "appropriately and proportionately." He added that even if the European Union did nothing, the US economy would still be hit with problems due to tariffs.

Related News
US Senate confirms Jay Bhattacharya to lead NIH
Stanford professor Jay Bhattacharya won Senate confirmation as director of the United States National Institutes of Health (NIH), the top US biomedical research agency. The upper congressional chamber confirmed Bhattacharya in a 53-47 vote, with all Republicans supporting him. Bhattacharya aligned with Health Secretary Robert F. Kennedy Jr.'s vision to "make America healthy again" and pledged to prioritize chronic disease research while fostering open...
Harris slams Trump for 'admiring dictators'
United States Vice President Kamala Harris, the Democratic presidential nominee, spoke in a recent NBC News interview about the choice Americans face in the upcoming election. She contrasted herself with former President Donald Trump, saying that voters must decide whether they want a leader who she claims openly admires authoritarian figures or not. "The American people are being presented with a choice here about whether we want a president who...
Moderna sued for patent infringement over COVID-19 vaccines
Northwestern University launched a lawsuit against Modern Inc. in Delaware federal court, accusing it of using the university's innovations to roll out its COVID-19 vaccine, Spikevax, without a license.Northwestern stressed that Moderna completed the first clinical trial of its COVID-19 vaccine a month before the World Health Organization declared the coronavirus outbreak a pandemic, adding that the pharmaceutical company "could not have achieved this...
Moderna gets greenlight for updated COVID jab
Moderna Inc. shared on Tuesday that it has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for its updated coronavirus vaccine, which targets the JN.1 variant of SARS-CoV-2."COVID-19 continues to present a serious health risk. Updated vaccines targeting circulating strains play a vital role in helping to protect those most at risk from severe illness and hospitalization, alleviating strain on the NHS," Britain's...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.